The amount of contingent proceeds from other method investment.

No definition available.

Name:	sfe_ContingentProceedsFromOtherMethodInvestment
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of contingent proceeds received from the sale of equity method investments.

+ References

No definition available.

+ Details

Name:	sfe_ContingentProceedsFromSaleOfEquityMethodInvestments
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the allocation of excess fair value under the equity method investment.

+ References

No definition available.

+ Details

Name:	sfe_EquityMethodInvestmentAllocationOfExcessFairValue
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Represents the value by which the carrying value exceeded the company's assets under the equity method investment.

+ References

No definition available.

+ Details

Name:	sfe_EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of other receivable related to indemnification escrow for realized gain or loss on disposal under equity method investments.

+ References

No definition available.

+ Details

Name:	sfe_EquityMethodInvestmentRealizedGainLossOnDisposalOtherReceivableRelatedToIndemnificationEscrow
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The amount of impairment of other method securities.

+ References

No definition available.

+ Details

Name:	sfe_ImpairmentOfOtherMethodSecurities
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of gain (loss) from sale of other method investment.

+ References

No definition available.

+ Details

Name:	sfe_OtherMethodInvestmentRealizedGainLoss
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of cash inflow from the sale of other method investment during the period.

+ References

No definition available.

+ Details

Name:	sfe_ProceedsFromSaleOfOtherMethodInvestment
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of gain (loss) from change in fair value for trading securities.

+ References

No definition available.

+ Details

Name:	sfe_TradingSecurityUnrealizedGainLoss
Namespace Prefix:	sfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of gain (loss) on sale or disposal of an equity method investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(b)(7)(c))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(b)(9)(a))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

Name:	us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of investment in equity security without readily determinable fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 321
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714

+ Details

Name:	us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Balance held at close of period in number of shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 50
-Paragraph 6
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-URI https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010

+ Details

Name:	us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585

+ Details

Name:	us-gaap_ProceedsFromSaleOfEquityMethodInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_FairValueByAssetClassAxis=us-gaap_GoodwillMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByAssetClassAxis=sfe_IntangibleAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_InvestmentTypeAxis=sfe_PreferredEquityInAcquirorInConnectionWithSaleOfZipnosisIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_LumesisIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_ZipnosisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_BrightHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_FlashtalkingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_WebLincIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_TrexGroupIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_VelanoVascularMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=sfe_AdvantedgeHealthcareSolutionsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 2 - Ownership Interests and Advances (Details Textual) - USD ($) $ in Thousands, shares in Millions	1 Months Ended			12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Equity Securities without Readily Determinable Fair Value, Amount		$ 5,313		$ 2,177	$ 5,313
Impairment of Other Method Securities					2,500
Equity Method Investment Assets Exceed Carrying Value Of Investment				2,700
Goodwill [Member]
Equity Method Investment Allocation of Excess Fair Value				2,500
Intangible Assets [Member]
Equity Method Investment Allocation of Excess Fair Value				$ 200
Preferred Equity in Acquiror in Connection with Sale of Zipnosis, Inc [Member]
Equity Securities without Readily Determinable Fair Value, Amount			$ 15,300
Lumesis, Inc. [Member]
Proceeds from Sale of Equity Method Investments	$ 5,500
Equity Method Investment, Realized Gain (Loss) on Disposal	4,900
"Equity Method Investment, Realized Gain (Loss) on Disposal, Other Receivable Related to Indemnification Escrow	$ 800
Zipnosis [Member]
Proceeds from Sale of Equity Method Investments			3,500
Equity Method Investment, Realized Gain (Loss) on Disposal			$ 17,300
Investment Owned, Balance, Shares (in shares)			1.3
Bright Health [Member]
Investment Owned, Balance, Shares (in shares)				1.3
Trading Security, Unrealized Gain (Loss)				$ 3,700	(10,800)
Flashtalking [Member]
Proceeds From Sale of Other Method Investment					45,000
Other Method Investment, Realized Gain (Loss)					32,500
Contingent Proceeds from Other Method Investment					500
WebLinc, Inc. [Member]
Proceeds from Sale of Equity Method Investments					3,600
Equity Method Investment, Realized Gain (Loss) on Disposal				$ 500	100
T-Rex Group, Inc [Member]
Equity Method Investment, Realized Gain (Loss) on Disposal			$ 900
Proceeds From Sale of Other Method Investment			$ 3,000
Velano Vascular [Member]
Proceeds from Sale of Equity Method Investments					4,000
Equity Method Investment, Realized Gain (Loss) on Disposal					$ 1,900
AdvantEdge Healthcare Solutions, Inc. [Member]
Contingent Proceeds from Sale of Equity Method Investments		$ 2,000